首页 产品目录 分子砌块 按反应类型 五元杂环胺化 (8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮

(8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮

(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

23214-92-8

中文名称

(8S,10S)-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮

英文名称

(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

别名

Doxorubicin hydrohloride;5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-;DOXORUBICIN;10-((3-amino-2,3,6-trideoxy-alpha-l-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione;(1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside;ADRIAMYCIN;Adriamycin Adriamycin;(8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione

标准英文名

(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione

MDL No.

MFCD00869292

分子式

C27H29NO11

分子量

543.17

精确分子量

543.17

SMILES

OC1=C(C(C2=CC=CC(OC)=C2C3=O)=O)C3=C(O)C4=C1C[C@](C(CO)=O)(O)C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N

标准SMILES

C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=C(C=CC=C3C(=O)C1=C2O)OC)C(=O)CO

用途

Doxorubicin hydrochloride is clinically used for the treatment of acute and chronic lymphocytic leukemia, as well as various solid tumors, including lymphoma (Hodgkin’s and non-Hodgkin’s), breast cancer, ovarian cancer, soft tissue sarcoma, osteosarcoma, rhabdomyosarcoma, Ewing’s sarcoma, Wilms’ tumor, neuroblastoma, gastric cancer, pancreatic cancer, hepatocellular carcinoma, prostate cancer, squamous cell carcinoma of the head and neck, testicular cancer, lung cancer, bladder cancer, medullary thyroid carcinoma, and other sarcomas. It is also effective in patients resistant to daunorubicin. Doxorubicin shows synergistic effects when combined with cytarabine, vincristine, or fluorouracil.

InChIKey

AOJJSUZBOXZQNB-TZSSRYMLSA-N

安全信息

SureRoute逆合成路线

1.  23214-92-8 逆合成路线 1

ACRLOH618
25316-40-9
现货
ACDTQJ324
7447-41-8
ACJUYX509
23214-92-8
来源: SureRoute

2.  23214-92-8 逆合成路线 2

ACTODZ152
23541-50-6
ACJUYX509
23214-92-8
来源: SureRoute

3.  23214-92-8 逆合成路线 3

—
—
—
—
—
—
ACJUYX509
23214-92-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手